Over $1M Bet On Bioventus? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying
Portfolio Pulse from Lisa Levin
Insiders have recently made significant purchases in four penny stocks: Diversified Healthcare Trust (DHC), Bioventus (BVS), Bionano Genomics (BNGO), and Bridgeline Digital (BLIN). These transactions may indicate confidence in the companies' prospects.
June 15, 2023 | 12:56 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
BLIN President and CEO Roger E Kahn acquired 24,611 shares at an average price of $1.16, spending $28.51 thousand.
The acquisition of a significant number of shares by BLIN's CEO indicates confidence in the company's prospects. This could lead to increased investor interest and a potential short-term increase in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
BNGO director Hannah Mamuszka acquired 65,789 shares at an average price of $0.76, spending around $50 thousand.
The acquisition of a notable number of shares by BNGO's director indicates confidence in the company's prospects. This could lead to increased investor interest and a potential short-term increase in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
BVS director John Bartholdson acquired 455,725 shares at an average price of $2.94, spending around $1.34 million.
The acquisition of a significant number of shares by BVS's director indicates confidence in the company's prospects. This could lead to increased investor interest and a potential short-term increase in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
DHC director Adam D Portnoy acquired 6,003,515 shares at an average price of $2.99, costing around $17.94 million.
The acquisition of a large number of shares by DHC's director indicates confidence in the company's prospects. This could lead to increased investor interest and a potential short-term increase in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100